Following up individuals after clinical conversion may produce modest quantitative shifts - such as stronger effects of brain atrophy, age × brain atrophy, and APOE ε4 on memory decline – consistent with established links among these measures and cognitive impairment. The gene discussed is APOE; the disease is Cognitive impairment.